HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.

Abstract
A 3-yr-old boy received valproic acid (VPA) for recurrent seizures. He developed coma and acute liver failure that were attributed to VPA toxicity, and underwent emergency orthotopic liver transplantation (OLTx). Despite good graft function, his neurological state worsened and led to death a few months later. The diagnosis of Alpers-Huttenlocher Syndrome (AHS) was suspected, subsequently to liver Tx, in view of ongoing neurologic deterioration and magnetic resonance imaging (MRI) findings. The syndrome, recessively inherited, associates brain degeneration with liver failure, and is now considered a mitochondrial disease. Enzyme activity deficiencies of the respiratory chain were identified in muscle mitochondria, as well as morphologic abnormalities of mitochondria in the explanted liver. Guidelines for diagnosis are presented, in order to differentiate the liver failure in AHS from that induced by genuine VPA toxicity. It is recommended to avoid liver Tx in patients with AHS given the fatal neurological course of the disease.
AuthorsA Delarue, O Paut, J M Guys, M F Montfort, V Lethel, B Roquelaure, J F Pellissier, J Sarles, J Camboulives
JournalPediatric transplantation (Pediatr Transplant) Vol. 4 Issue 1 Pg. 67-71 (Feb 2000) ISSN: 1397-3142 [Print] Denmark
PMID10731063 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticonvulsants
  • Valproic Acid
Topics
  • Anticonvulsants (adverse effects)
  • Brain (pathology)
  • Child, Preschool
  • Diagnosis, Differential
  • Diagnostic Errors
  • Diffuse Cerebral Sclerosis of Schilder (diagnosis)
  • Humans
  • Liver Failure, Acute (chemically induced, diagnosis, surgery)
  • Liver Transplantation
  • Magnetic Resonance Imaging
  • Male
  • Medical Errors
  • Mitochondrial Myopathies (diagnosis)
  • Valproic Acid (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: